跳至主要内容
临床试验/NCT02337556
NCT02337556已完成不适用

The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU

Société des Produits Nestlé (SPN)14 个研究点 分布在 2 个国家目标入组 106 人开始时间: 2014年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
106
试验地点
14
主要终点
Glucose variability - Number of glycemic events outside the serum glucose range of 110-150 mg/dl

研究概览

简要总结

To compare the nutritional effect on blood glucose of two commercially available enteral diets in overweight or obese patients in the Intensive Care Unit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • New admit to the ICU and expected to remain in ICU 5 days
  • Ventilator dependent up to 48 hours prior to admission to the study
  • Requiring tube feeding enteral nutrition (EN) 5 days
  • Expected to receive 50% of caloric needs within 72 hours
  • Body Mass Index 26-45

排除标准

  • Trauma patients
  • Major surgery in past 30 days or planned for next 7 days
  • Diabetes mellitus (DM) type 1
  • Admitted with diagnosis of diabetic ketoacidosis as primary diagnosis
  • Pregnant or lactating
  • Non-functioning GI tract
  • Use of parenteral nutrition in past 30 days
  • Admitted with burns > 20% body surface area
  • Traumatic brain injury
  • Hemodynamic instability that prevents delivery of EN > 24hr
  • Unable to access GI tract for feeding via tube, unable to receive EN
  • Other contraindication to tube feeding
  • Any other condition that would not allow patient to complete the study protocol
  • Use of enteral formula at enrollment that cannot be changed to the investigational product

结局指标

主要结局

Glucose variability - Number of glycemic events outside the serum glucose range of 110-150 mg/dl

时间窗: First seven days in the ICU

Number of glycemic events outside the serum glucose range of 110-150 mg/dl

次要结局

  • Glucose variability - Number of episodes of hyperglycemia (glucose > 180 mg/dl)(First seven days in the ICU)
  • Glucose variability - Number of glycemic events between 80-110 mg/dl and 150-180 mg/dl(First seven days in the ICU)
  • Glucose variability - Number of episodes of hypoglycemia (glucose < 80 mg/dl)(First seven days in the ICU)
  • Glucose variability - Average glucose levels(First seven days in the ICU)
  • Need for exogenous insulin administration(First seven days in the ICU)
  • Nursing time(First seven days in the ICU)
  • Need for exogenous glucose administration(First seven days in the ICU)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验

The DIVINE Study: DIetary Management of Glucose... | 临床试验